$MDT (Medtronic Plc) — investor discussion on X

Five-factor rating: Hold (sector percentile 33.8%)

Graded daily on value B+, growth B-, profitability B, momentum B-, revisions C-. Sector-relative, identical for every user.

Most active credible voices on $MDT

@dividendtalks (Dividend Talks on YouTube) — 20 mentions · 79.7K followers
@schaeffers (Schaeffer's Investment Research) — 14 mentions · 14.7K followers
@chitrader (CHItrader) — 11 mentions · 7.9K followers

Recent headlines featuring $MDT

2026-09-01: U.S. 10-year yield nears 4.80% as Japan’s 30-year hits 3.00%

Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $MDT are available with SpikePanel Pro.

Stock Ratings · Today Headlines · SpikePanel

For richer charts and full features, open SpikePanel on desktop.

$MDT — what investors on X are saying · SpikePanel

$MDTMedtronic Plc · Medical - Devices · $129B

$101.19

-0.4%

Event thread

Key events, in time order

19 items

2026-10-208-K filing
8-K: Item 5.02, Item 5.07, Item 7.01, Item 9.01
D1 +2.0% · +5d -0.7%
2026-10-02 → 10-15Capital
Medtronic Completes MiniMed Separation, MiniMed Lists Independently
Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.
D1 -0.1% · +5d +2.4%
3 waves of this story
- 2026-10-02 Barron's reports tax-free split-off offer losing appeal to investors
- 2026-10-13 Offer expired at max exchange ratio; MMED shares expected this week
- 2026-10-15 Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.

17 earlier events

2026-09-09 → 09-23CompanyBull
Medtronic beats Q1, raises FY27 guidance to 7.25%-7.75%
Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum
D1 -0.5% · +5d +0.8%
2 waves of this story
- 2026-09-09 Company lifts guidance, cites AI/robotics/ablation growth; margin pressure and competition remain challenges
- 2026-09-23 Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum
2026-09-188-K filing
8-K: Item 8.01, Item 9.01
D1 -0.7% · +5d -3.8%
2026-09-16ProductBull
Medtronic's LigaSure Receives FDA Clearance for Hugo RAS
FDA clearance expands robotic surgery applications, strengthening product portfolio
D1 -1.2% · +5d -3.6%
2026-09-14Capital
Medtronic Launches Exchange Offer to Complete MiniMed Separation
Shareholders can exchange shares; separation advances as MiniMed files S-4
D1 +3.1% · +5d -2.2%
2026-08-28 → 09-04EarningsBull
Medtronic Beats Q1 Estimates, Raises Guidance; Analysts Lift Forecasts
Strongest revenue growth in a decade, driven by cardiovascular business
D1 +1.4% · +5d +3.2%
4 waves of this story
- 2026-08-28 Multiple sources confirm earnings date; analysts project EPS $1.39 and revenue $9.47B
- 2026-09-01 Revenue $9.76B beat, adj EPS $1.45 beat, raises FY27 profit and revenue outlook
- 2026-09-02 Q1 revenue and EPS beat, FY27 guidance raised, analysts follow
- 2026-09-04 Strongest revenue growth in a decade, driven by cardiovascular business
2026-09-01 → 09-03CapitalBull
Medtronic Expands Surgical Robotics Access via Cornerstone Robotics Partnership
Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness
D1 +1.5% · +5d -0.2%
3 waves of this story
- 2026-09-01 Bolsters surgical robotics and heart valve innovation, strengthening growth platforms
- 2026-09-02 After investment, strategic partnership aims to increase global access
- 2026-09-03 Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness
2026-09-018-K filing
8-K: Item 2.02, Item 9.01
D1 +1.5% · +5d -0.2%
2026-09-01Earnings
Earnings report
D1 +1.5% · +5d -0.2%
2026-08-20Company
Medtronic declares $0.72 per share cash dividend for Q2 FY2027
Board approves quarterly dividend, continuing shareholder return policy
D1 -1.9% · +5d -2.5%
2026-08-18Earnings
Earnings report
D1 +1.6% · +5d -1.0%
2026-08-06ProductBull
Medtronic Expands CE Mark for Affera System to Ventricular Arrhythmias
Additional independent source confirms the CE Mark expansion, reinforcing the product milestone
D1 -0.1% · +5d +5.4%
2 waves of this story
- 2026-08-06 Sphere-9 first to get CE mark for ventricular ablation, offering new minimally invasive option
- 2026-08-06 Additional independent source confirms the CE Mark expansion, reinforcing the product milestone
2026-07-28Analyst
UBS upgrades to Buy
D1 +3.2% · +5d -0.8%
2026-07-21CapitalBear
Swedish Pension Fund Trims Medtronic Stake by 3.9% in Q1
Institutional stake reduction signals portfolio rebalancing, though modest
D1 -1.1% · +5d +5.5%
2026-07-21ProductBull
Medtronic to Unveil AI Surgical Platform Touch Surgery Aide
FDA-cleared real-time AI on NVIDIA infrastructure marks new era in surgery
D1 -1.1% · +5d +5.5%
2026-07-20CapitalBull
Decker Wealth Opens $5.08M Position in Medtronic in Q1
13F filing reveals new institutional stake, indicating fund flow
D1 +0.1% · +5d +1.1%
2026-07-20Earnings
Medtronic to Report Q1 FY2027 Results on September 1
Company sets official date for Q1 FY2027 earnings release
D1 +0.1% · +5d +1.1%
2026-07-16CapitalBull
Medtronic completes SPR acquisition, expanding pain therapy portfolio
Adds category-defining SPRINT PNS technology to broadest pain therapy portfolio
D1 +3.8% · +5d -1.9%

①

Bull vs bear

by direction · sourced

Bull signals0

None yet

Bear signals0

None yet

Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice

⑩

Discussion

be the first

Be civil · your views are your own

No comments yet.

Facts and opinions separated · All items sourced · Not investment advice

Event thread

Key events, in time order

19 items

2026-10-208-K filing
8-K: Item 5.02, Item 5.07, Item 7.01, Item 9.01
D1 +2.0% · +5d -0.7%
2026-10-02 → 10-15Capital
Medtronic Completes MiniMed Separation, MiniMed Lists Independently
Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.
D1 -0.1% · +5d +2.4%
3 waves of this story
- 2026-10-02 Barron's reports tax-free split-off offer losing appeal to investors
- 2026-10-13 Offer expired at max exchange ratio; MMED shares expected this week
- 2026-10-15 Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.
2026-09-09 → 09-23CompanyBull
Medtronic beats Q1, raises FY27 guidance to 7.25%-7.75%
Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum
D1 -0.5% · +5d +0.8%
2 waves of this story
- 2026-09-09 Company lifts guidance, cites AI/robotics/ablation growth; margin pressure and competition remain challenges
- 2026-09-23 Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum
2026-09-188-K filing
8-K: Item 8.01, Item 9.01
D1 -0.7% · +5d -3.8%
2026-09-16ProductBull
Medtronic's LigaSure Receives FDA Clearance for Hugo RAS
FDA clearance expands robotic surgery applications, strengthening product portfolio
D1 -1.2% · +5d -3.6%

14 earlier events

2026-09-14Capital
Medtronic Launches Exchange Offer to Complete MiniMed Separation
Shareholders can exchange shares; separation advances as MiniMed files S-4
D1 +3.1% · +5d -2.2%
2026-08-28 → 09-04EarningsBull
Medtronic Beats Q1 Estimates, Raises Guidance; Analysts Lift Forecasts
Strongest revenue growth in a decade, driven by cardiovascular business
D1 +1.4% · +5d +3.2%
4 waves of this story
- 2026-08-28 Multiple sources confirm earnings date; analysts project EPS $1.39 and revenue $9.47B
- 2026-09-01 Revenue $9.76B beat, adj EPS $1.45 beat, raises FY27 profit and revenue outlook
- 2026-09-02 Q1 revenue and EPS beat, FY27 guidance raised, analysts follow
- 2026-09-04 Strongest revenue growth in a decade, driven by cardiovascular business
2026-09-01 → 09-03CapitalBull
Medtronic Expands Surgical Robotics Access via Cornerstone Robotics Partnership
Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness
D1 +1.5% · +5d -0.2%
3 waves of this story
- 2026-09-01 Bolsters surgical robotics and heart valve innovation, strengthening growth platforms
- 2026-09-02 After investment, strategic partnership aims to increase global access
- 2026-09-03 Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness
2026-09-018-K filing
8-K: Item 2.02, Item 9.01
D1 +1.5% · +5d -0.2%
2026-09-01Earnings
Earnings report
D1 +1.5% · +5d -0.2%
2026-08-20Company
Medtronic declares $0.72 per share cash dividend for Q2 FY2027
Board approves quarterly dividend, continuing shareholder return policy
D1 -1.9% · +5d -2.5%
2026-08-18Earnings
Earnings report
D1 +1.6% · +5d -1.0%
2026-08-06ProductBull
Medtronic Expands CE Mark for Affera System to Ventricular Arrhythmias
Additional independent source confirms the CE Mark expansion, reinforcing the product milestone
D1 -0.1% · +5d +5.4%
2 waves of this story
- 2026-08-06 Sphere-9 first to get CE mark for ventricular ablation, offering new minimally invasive option
- 2026-08-06 Additional independent source confirms the CE Mark expansion, reinforcing the product milestone
2026-07-28Analyst
UBS upgrades to Buy
D1 +3.2% · +5d -0.8%
2026-07-21CapitalBear
Swedish Pension Fund Trims Medtronic Stake by 3.9% in Q1
Institutional stake reduction signals portfolio rebalancing, though modest
D1 -1.1% · +5d +5.5%
2026-07-21ProductBull
Medtronic to Unveil AI Surgical Platform Touch Surgery Aide
FDA-cleared real-time AI on NVIDIA infrastructure marks new era in surgery
D1 -1.1% · +5d +5.5%
2026-07-20CapitalBull
Decker Wealth Opens $5.08M Position in Medtronic in Q1
13F filing reveals new institutional stake, indicating fund flow
D1 +0.1% · +5d +1.1%
2026-07-20Earnings
Medtronic to Report Q1 FY2027 Results on September 1
Company sets official date for Q1 FY2027 earnings release
D1 +0.1% · +5d +1.1%
2026-07-16CapitalBull
Medtronic completes SPR acquisition, expanding pain therapy portfolio
Adds category-defining SPRINT PNS technology to broadest pain therapy portfolio
D1 +3.8% · +5d -1.9%

$MDT (Medtronic Plc) — investor discussion on X

Five-factor rating: Hold (sector percentile 33.8%)

Most active credible voices on $MDT

Recent headlines featuring $MDT

$MDT (Medtronic Plc) — investor discussion on X

Five-factor rating: Hold (sector percentile 33.8%)

Most active credible voices on $MDT

Recent headlines featuring $MDT

8-K: Item 5.02, Item 5.07, Item 7.01, Item 9.01

Medtronic Completes MiniMed Separation, MiniMed Lists Independently

Medtronic beats Q1, raises FY27 guidance to 7.25%-7.75%

8-K: Item 8.01, Item 9.01

Medtronic's LigaSure Receives FDA Clearance for Hugo RAS

Medtronic Launches Exchange Offer to Complete MiniMed Separation

Medtronic Beats Q1 Estimates, Raises Guidance; Analysts Lift Forecasts

Medtronic Expands Surgical Robotics Access via Cornerstone Robotics Partnership

8-K: Item 2.02, Item 9.01

Earnings report

Medtronic declares $0.72 per share cash dividend for Q2 FY2027

Earnings report

Medtronic Expands CE Mark for Affera System to Ventricular Arrhythmias

UBS upgrades to Buy

Swedish Pension Fund Trims Medtronic Stake by 3.9% in Q1

Medtronic to Unveil AI Surgical Platform Touch Surgery Aide

Decker Wealth Opens $5.08M Position in Medtronic in Q1

Medtronic to Report Q1 FY2027 Results on September 1

Medtronic completes SPR acquisition, expanding pain therapy portfolio

Bull vs bear

Discussion

8-K: Item 5.02, Item 5.07, Item 7.01, Item 9.01

Medtronic Completes MiniMed Separation, MiniMed Lists Independently

Medtronic beats Q1, raises FY27 guidance to 7.25%-7.75%

8-K: Item 8.01, Item 9.01

Medtronic's LigaSure Receives FDA Clearance for Hugo RAS

Medtronic Launches Exchange Offer to Complete MiniMed Separation

Medtronic Beats Q1 Estimates, Raises Guidance; Analysts Lift Forecasts

Medtronic Expands Surgical Robotics Access via Cornerstone Robotics Partnership

8-K: Item 2.02, Item 9.01

Earnings report

Medtronic declares $0.72 per share cash dividend for Q2 FY2027

Earnings report

Medtronic Expands CE Mark for Affera System to Ventricular Arrhythmias

UBS upgrades to Buy

Swedish Pension Fund Trims Medtronic Stake by 3.9% in Q1

Medtronic to Unveil AI Surgical Platform Touch Surgery Aide

Decker Wealth Opens $5.08M Position in Medtronic in Q1

Medtronic to Report Q1 FY2027 Results on September 1

Medtronic completes SPR acquisition, expanding pain therapy portfolio